![](https://webarchive.library.unt.edu/web/20081010045425im_/http://www.nci.nih.gov/images/spacer.gif) |
¿Preguntas sobre el cáncer?
![](https://webarchive.library.unt.edu/web/20081010045425im_/http://www.nci.nih.gov/images/spacer.gif)
|
1-800-422-6237
(1-800-4-CANCER)
|
![](https://webarchive.library.unt.edu/web/20081010045425im_/http://www.nci.nih.gov/images/spacer.gif)
|
Llame de lunes a viernes de 9:00 a.m. a 4:30 p.m., hora local en Estados Unidos y sus territorios. |
|
![](https://webarchive.library.unt.edu/web/20081010045425im_/http://www.nci.nih.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/web/20081010045425im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/web/20081010045425im_/http://www.nci.nih.gov/images/spacer.gif)
| Medicamento que se usa para tratar el cáncer de testículo y el cáncer de pulmón de células pequeñas. Asimismo, está en estudio para el tratamiento de varios otros tipos de cáncer. Vepesid bloquea ciertas enzimas necesarias para la multiplicación celular y la reparación del ADN, y puede destruir las células cancerosas. Es un tipo de derivado de la podofilotoxina y un tipo de inhibidor de la topoisomerasa. También se llama etopósido y Toposar. |
![](https://webarchive.library.unt.edu/web/20081010045425im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/web/20081010045425im_/http://www.nci.nih.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/web/20081010045425im_/http://www.nci.nih.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/web/20081010045425im_/http://www.nci.nih.gov/images/spacer.gif) |